{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T13:36:23Z","timestamp":1790516183884,"version":"4.1.0"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004431","name":"Fondation de France","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004431","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002915","name":"Fondation pour la Recherche M\u00e9dicale (FRM)","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002915","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Nouvelle Soci\u00e9t\u00e9 Fran\u00e7aise d\u2019Ath\u00e9roscl\u00e9rose (NSFA)"},{"name":"Groupe d\u2019Etudes sur l\u2019H\u00e9mostase et la Thrombose (GEHT)"},{"name":"Agence Nationale de la Recherche (ANR)"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Prostaglandins &amp; Other Lipid Mediators"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.prostaglandins.2015.10.001","type":"journal-article","created":{"date-parts":[[2015,10,22]],"date-time":"2015-10-22T23:20:24Z","timestamp":1445556024000},"page":"4-16","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"PA","title":["The receptor EP3 to PGE2: A rational target to prevent atherothrombosis without inducing bleeding"],"prefix":"10.1016","volume":"121","author":[{"given":"Marie-Anne","family":"Mawhin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peggy","family":"Tilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3256-5623","authenticated-orcid":false,"given":"Jean-Etienne","family":"Fabre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prostaglandins.2015.10.001_bib0005","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.cell.2011.04.005","article-title":"Macrophages in the pathogenesis of atherosclerosis","volume":"145","author":"Moore","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.prostaglandins.2015.10.001_bib0010","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1161\/01.CIR.0000087480.94275.97","article-title":"From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: part I","volume":"108","author":"Naghavi","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.prostaglandins.2015.10.001_bib0015","doi-asserted-by":"crossref","first-page":"H717","DOI":"10.1152\/ajpheart.00005.2008","article-title":"Necrotic core thickness and positive arterial remodeling index: emergent biomechanical factors for evaluating the risk of plaque rupture","volume":"295","author":"Ohayon","year":"2008","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.prostaglandins.2015.10.001_bib0020","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1056\/NEJMra071014","article-title":"Platelet activation and atherothrombosis","volume":"357","author":"Davi","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.prostaglandins.2015.10.001_bib0025","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMra043430","article-title":"Inflammation, atherosclerosis, and coronary artery disease","volume":"352","author":"Hansson","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.prostaglandins.2015.10.001_bib0030","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1001\/archinte.162.21.2405","article-title":"The underlying risk of death after myocardial infarction in the absence of treatment","volume":"162","author":"Law","year":"2002","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.prostaglandins.2015.10.001_bib0035","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1016\/S0140-6736(11)60764-2","article-title":"Heparin plus a glycoprotein IIb\/IIIa inhibitor versus bivalirudin monotherapy and paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction (HORIZONS-AMI): final 3-year results from a multicentre, randomised controlled trial","volume":"377","author":"Stone","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.prostaglandins.2015.10.001_bib0040","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1056\/NEJMe0706859","article-title":"Intensifying platelet inhibition-navigating between Scylla and Charybdis","volume":"357","author":"Bhatt","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.prostaglandins.2015.10.001_bib0045","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","article-title":"Prasugrel versus clopidogrel in patients with acute coronary syndromes","volume":"357","author":"Wiviott","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.prostaglandins.2015.10.001_bib0050","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1161\/CIRCULATIONAHA.105.567297","article-title":"Tissue factor in cardiovascular diseases: molecular mechanisms and clinical implications","volume":"113","author":"Steffel","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.prostaglandins.2015.10.001_bib0055","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1159\/000216835","article-title":"The Prevention of cerebrovascular and cardiovascular Events of ischemic origin with terutroban in patients with a history of ischemic stroke or transient ischemic attack (PERFORM) study: baseline characteristics of the population","volume":"27","author":"Bousser","year":"2009","journal-title":"Cerebrovasc. Dis."},{"key":"10.1016\/j.prostaglandins.2015.10.001_bib0060","doi-asserted-by":"crossref","first-page":"11660","DOI":"10.1074\/jbc.274.17.11660","article-title":"Arachidonic acid is preferentially metabolized by cyclooxygenase-2 to prostacyclin and prostaglandin E2","volume":"274","author":"Brock","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.prostaglandins.2015.10.001_bib0065","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1084\/jem.20061617","article-title":"Vascular wall-produced prostaglandin E2 exacerbates arterial thrombosis and atherothrombosis through platelet EP3 receptors","volume":"204","author":"Gross","year":"2007","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.prostaglandins.2015.10.001_bib0070","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1161\/01.CIR.0000104565.78013.AD","article-title":"Cyclooxygenase isoforms and platelet vessel wall interactions in the apolipoprotein E knockout mouse model of atherosclerosis","volume":"108","author":"Belton","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.prostaglandins.2015.10.001_bib0075","doi-asserted-by":"crossref","first-page":"296","DOI":"10.2183\/pjab.83.296","article-title":"Physiology and pathophysiology of prostanoid receptors","volume":"83","author":"Narumiya","year":"2007","journal-title":"Proc. Jpn. Acad. Ser. B Phys. Biol. Sci."},{"key":"10.1016\/j.prostaglandins.2015.10.001_bib0080","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/36342","article-title":"The prostaglandin receptor EP4 triggers remodelling of the cardiovascular system at birth","volume":"390","author":"Nguyen","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.prostaglandins.2015.10.001_bib0085","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1007\/s10753-009-9176-5","article-title":"Different mechanisms in formation and prevention of indomethacin-induced gastric ulcers","volume":"33","author":"Suleyman","year":"2010","journal-title":"Inflammation"},{"key":"10.1016\/j.prostaglandins.2015.10.001_bib0090","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0065-2423(10)51005-9","article-title":"Receptors and their roles in mucosal protection and ulcer healing in the gastrointestinal tract","volume":"51","author":"Takeuchi","year":"2010","journal-title":"Adv. Clin. Chem."},{"key":"10.1016\/j.prostaglandins.2015.10.001_bib0095","doi-asserted-by":"crossref","first-page":"12752","DOI":"10.1074\/jbc.M212097200","article-title":"Prostaglandin E2 protects gastric mucosal cells from apoptosis via EP2 and EP4 receptor activation","volume":"278","author":"Hoshino","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.prostaglandins.2015.10.001_bib0100","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0090-6980(72)90063-9","article-title":"Prostaglandin E2: effects on aggregation, shape change and cyclic AMP of rat platelets","volume":"1","author":"Shio","year":"1972","journal-title":"Prostaglandins"},{"key":"10.1016\/j.prostaglandins.2015.10.001_bib0105","first-page":"45","article-title":"Effect of prostaglandin E2 and aspirin on the secondary aggregation of human platelets","volume":"236","author":"Shio","year":"1972","journal-title":"Nature"},{"key":"10.1016\/j.prostaglandins.2015.10.001_bib0110","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/258337a0","article-title":"Calcium-dependent stimulation of platelet aggregation by PGE2","volume":"258","author":"MacIntyre","year":"1975","journal-title":"Nature"},{"key":"10.1016\/j.prostaglandins.2015.10.001_bib0115","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0014-2999(85)90620-X","article-title":"The effects of PGE2 and CL 115,347, an antihypertensive PGE2 analogue, on human blood platelet behaviour and vascular contractility","volume":"114","author":"Gray","year":"1985","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.prostaglandins.2015.10.001_bib0120","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0014-2999(91)90124-9","article-title":"Interactions between prostaglandin E2 and inhibitors of platelet aggregation which act through cyclic AMP","volume":"194","author":"Gray","year":"1991","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.prostaglandins.2015.10.001_bib0125","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1182\/blood.V82.9.2704.2704","article-title":"Prostaglandin E2 potentiates platelet aggregation by priming protein kinase C","volume":"82","author":"Vezza","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.prostaglandins.2015.10.001_bib0130","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/0090-6980(80)90170-7","article-title":"On the multiplicity of platelet prostaglandin receptors. I. Evaluation of competitive antagonism by aggregometry","volume":"19","author":"Andersen","year":"1980","journal-title":"Prostaglandins"},{"key":"10.1016\/j.prostaglandins.2015.10.001_bib0135","first-page":"45","article-title":"Cyclic AMP. turnover in response to prostaglandins in intact platelets: evidence for separate stimulatory and inhibitory prostaglandin receptors","volume":"12","author":"Ashby","year":"1988","journal-title":"Second Messengers Phosphoprot."},{"key":"10.1016\/j.prostaglandins.2015.10.001_bib0140","first-page":"31","article-title":"Interactions among prostaglandin receptors","volume":"4","author":"Ashby","year":"1994","journal-title":"Receptor"},{"key":"10.1016\/j.prostaglandins.2015.10.001_bib0145","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1046\/j.1365-2141.1998.00910.x","article-title":"Distribution of prostaglandin IP and EP receptor subtypes and isoforms in platelets and human umbilical artery smooth muscle cells","volume":"102","author":"Paul","year":"1998","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.prostaglandins.2015.10.001_bib0150","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1161\/ATVBAHA.110.216374","article-title":"The prostaglandin E2 receptor EP4 is expressed by human platelets and potently inhibits platelet aggregation and thrombus formation","volume":"30","author":"Philipose","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.prostaglandins.2015.10.001_bib0155","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1124\/jpet.110.174821","article-title":"Prostaglandin E2 differentially modulates human platelet function through the prostanoid EP2 and EP3 receptors","volume":"336","author":"Petrucci","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.prostaglandins.2015.10.001_bib0160","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ejphar.2014.06.030","article-title":"Reciprocal regulation of human platelet function by endogenous prostanoids and through multiple prostanoid receptors","volume":"740","author":"Hubertus","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.prostaglandins.2015.10.001_bib0165","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1161\/hc3601.094003","article-title":"Increased bleeding tendency and decreased susceptibility to thromboembolism in mice lacking the prostaglandin E receptor subtype EP(3)","volume":"104","author":"Ma","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.prostaglandins.2015.10.001_bib0170","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1160\/TH10-01-0043","article-title":"Selective activation of the prostaglandin E2 receptor subtype EP2 or EP4 leads to inhibition of platelet aggregation","volume":"104","author":"Kuriyama","year":"2010","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.prostaglandins.2015.10.001_bib0175","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1172\/JCI10881","article-title":"Activation of the murine EP3 receptor for PGE(2) inhibits cAMP production and promotes platelet aggregation","volume":"107","author":"Fabre","year":"2001","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.prostaglandins.2015.10.001_bib0180","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3109\/09537101003718065","article-title":"The role of prostanoid receptors in mediating the effects of PGE(2) on human platelet function","volume":"21","author":"Iyu","year":"2010","journal-title":"Platelets"},{"key":"10.1016\/j.prostaglandins.2015.10.001_bib0185","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1016\/j.thromres.2010.04.003","article-title":"PGE2 decreases reactivity of human platelets by activating EP2 and EP4","volume":"126","author":"Smith","year":"2010","journal-title":"Thromb. Res."},{"key":"10.1016\/j.prostaglandins.2015.10.001_bib0190","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1093\/cvr\/cvt276","article-title":"Blocking the EP3 receptor for PGE2 with DG-041 decreases thrombosis without impairing haemostatic competence","volume":"101","author":"Tilly","year":"2014","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.prostaglandins.2015.10.001_bib0195","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1016\/j.bcp.2003.12.028","article-title":"Control of platelet activation by cyclic AMP turnover and cyclic nucleotide phosphodiesterase type-3","volume":"67","author":"Feijge","year":"2004","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.prostaglandins.2015.10.001_bib0200","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0167-4889(87)90049-8","article-title":"Modulation of Ca2+ fluxes in isolated platelet vesicles: effects of cAMP-dependent protein kinase and protein kinase inhibitor on Ca2+ sequestration and release","volume":"931","author":"Hettasch","year":"1987","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.prostaglandins.2015.10.001_bib0205","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0300-9084(87)90020-4","article-title":"Relationship between cAMP and Ca2+ fluxes in human platelet membranes","volume":"69","author":"Enouf","year":"1987","journal-title":"Biochimie"},{"key":"10.1016\/j.prostaglandins.2015.10.001_bib0210","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/0167-4889(87)90087-5","article-title":"Possible role of a cAMP-dependent phosphorylation in the calcium release mediated by inositol 1,4,5-trisphosphate in human platelet membrane vesicles","volume":"928","author":"Enouf","year":"1987","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.prostaglandins.2015.10.001_bib0215","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1172\/JCI27540","article-title":"Cyclooxygenases, microsomal prostaglandin E synthase-1, and cardiovascular function","volume":"116","author":"Cheng","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.prostaglandins.2015.10.001_bib0220","doi-asserted-by":"crossref","first-page":"e45008","DOI":"10.1371\/journal.pone.0045008","article-title":"In vivo detection of activated platelets allows characterizing rupture of atherosclerotic plaques with molecular magnetic resonance imaging in mice","volume":"7","author":"von Elverfeldt","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.prostaglandins.2015.10.001_bib0225","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1021\/jm9005912","volume":"53","author":"Singh","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.prostaglandins.2015.10.001_bib0230","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1021\/cb8002094","article-title":"Antagonists of the EP(3) receptor for prostaglandin E(2) are novel antiplatelet agents that do not prolong bleeding","volume":"20","author":"Singh","year":"2009","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.prostaglandins.2015.10.001_bib0235","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1080\/09537100802351073","article-title":"DG-041 inhibits the EP3 prostanoid receptor\u2014a new target for inhibition of platelet function in atherothrombotic disease","volume":"19","author":"Heptinstall","year":"2008","journal-title":"Platelets"},{"key":"10.1016\/j.prostaglandins.2015.10.001_bib0240","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1161\/01.ATV.0000183884.06371.52","article-title":"Tissue-specific hemostasis in mice","volume":"25","author":"Mackman","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.prostaglandins.2015.10.001_bib0245","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1182\/blood.V77.12.2547.2547","article-title":"The bleeding time does not predict surgical bleeding","volume":"77","author":"Lind","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.prostaglandins.2015.10.001_bib0250","doi-asserted-by":"crossref","first-page":"3397","DOI":"10.1161\/STROKEAHA.108.517482","article-title":"Experimental model of warfarin-associated intracerebral hemorrhage","volume":"39","author":"Foerch","year":"2008","journal-title":"Stroke"},{"key":"10.1016\/j.prostaglandins.2015.10.001_bib0255","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1152\/physrev.1999.79.4.1193","article-title":"Prostanoid receptors: structures, properties, and functions","volume":"79","author":"Narumiya","year":"1999","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.prostaglandins.2015.10.001_bib0260","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/251721a0","article-title":"Effects of prostaglandin E2 on human platelet adenyl cyclase and aggregation","volume":"251","author":"Bruno","year":"1974","journal-title":"Nature"},{"key":"10.1016\/j.prostaglandins.2015.10.001_bib0265","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1476-5381.1993.tb12810.x","article-title":"Potentiation of aggregation and inhibition of adenylate cyclase in human platelets by prostaglandin E analogues","volume":"108","author":"Matthews","year":"1993","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.prostaglandins.2015.10.001_bib0270","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1160\/TH09-12-0815","article-title":"The EP3-agonist sulprostone, but not prostaglandin E2 potentiates platelet aggregation in human blood","volume":"103","author":"Schober","year":"2010","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.prostaglandins.2015.10.001_bib0275","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0022-3565(25)21020-5","article-title":"Adenylate cyclase activation determines the effect of thromboxane synthase inhibitors on platelet aggregation in vitro. Comparison of platelets from responders and nonresponders","volume":"246","author":"Gresele","year":"1988","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.prostaglandins.2015.10.001_bib0280","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/s11239-011-0577-6","article-title":"The role of PGE(2) in human atherosclerotic plaque on platelet EP(3) and EP(4) receptor activation and platelet function in whole blood","volume":"32","author":"Schober","year":"2011","journal-title":"J. Thromb. Thrombolysis"},{"key":"10.1016\/j.prostaglandins.2015.10.001_bib0285","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/277659a0","article-title":"Novel [alpha]2-adrenoreceptors primarily responsible for inducing human platelet aggregation","volume":"277","author":"Grant","year":"1979","journal-title":"Nature"},{"key":"10.1016\/j.prostaglandins.2015.10.001_bib0290","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1126\/science.2823383","article-title":"Cloning, sequencing, and expression of the gene coding for the human platelet alpha 2-adrenergic receptor","volume":"238","author":"Kobilka","year":"1987","journal-title":"Science"},{"key":"10.1016\/j.prostaglandins.2015.10.001_bib0295","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1749-6632.1972.tb16287.x","article-title":"Cyclic 3\u2032,5\u2032-adenosine monophosphate in human blood platelets IV: regulatory role of cyclic AMP in platelet function","volume":"201","author":"Salzman","year":"1972","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.prostaglandins.2015.10.001_bib0300","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1074\/jbc.275.3.1763","article-title":"\u03b12A-Adrenergic receptor stimulation potentiates calcium release in platelets by modulating cAMP levels","volume":"275","author":"Keularts","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.prostaglandins.2015.10.001_bib0305","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/200763a0","article-title":"Some effects of adrenaline and anti-adrenaline compounds on platelets in vitro and in vivo","volume":"200","author":"O\u2019Brien","year":"1963","journal-title":"Nature"},{"key":"10.1016\/j.prostaglandins.2015.10.001_bib0310","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1113\/jphysiol.1967.sp008369","article-title":"Effects of adrenaline on human blood platelets","volume":"193","author":"Mills","year":"1967","journal-title":"J. Physiol."},{"key":"10.1016\/j.prostaglandins.2015.10.001_bib0315","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/BF01855665","article-title":"Possible interaction of platelets and adrenaline in the early phase of myocardial infarction","volume":"187","author":"Seitz","year":"1987","journal-title":"Res. Exp. Med."},{"key":"10.1016\/j.prostaglandins.2015.10.001_bib0320","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1007\/BF01964968","article-title":"Potentiation by adrenaline of human platelet activation and the inhibition by the alpha-adrenergic antagonist nicergoline of platelet adhesion, secretion and aggregation","volume":"18","author":"Lanza","year":"1986","journal-title":"Agents Actions"},{"key":"10.1016\/j.prostaglandins.2015.10.001_bib0325","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0031-6997(25)06784-5","article-title":"Classification of prostanoid receptors: properties, distribution, and structure of the receptor and their subtypes","volume":"46","author":"Coleman","year":"1994","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.prostaglandins.2015.10.001_bib0330","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.prostaglandins.2010.11.001","article-title":"PGE1 and PGE2 modify platelet function through different prostanoid receptors","volume":"94","author":"Iyu","year":"2011","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1016\/j.prostaglandins.2015.10.001_bib0335","doi-asserted-by":"crossref","first-page":"344","DOI":"10.3109\/09537104.2011.625575","article-title":"PGE(2) reverses G(s)-mediated inhibition of platelet aggregation by interaction with EP3 receptors, but adds to non-G(s)-mediated inhibition of platelet aggregation by interaction with EP4 receptors","volume":"23","author":"Glenn","year":"2012","journal-title":"Platelets"},{"key":"10.1016\/j.prostaglandins.2015.10.001_bib0340","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1161\/hc3401.093152","article-title":"Overexpression of functionally coupled cyclooxygenase-2 and prostaglandin E synthase in symptomatic atherosclerotic plaques as a basis of prostaglandin E2-dependent plaque instability","volume":"104","author":"Cipollone","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.prostaglandins.2015.10.001_bib0345","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1084\/jem.20112322","article-title":"Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo","volume":"209","author":"von Br\u00fchl","year":"2012","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.prostaglandins.2015.10.001_bib0350","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3389\/fimmu.2012.00385","article-title":"The emerging role of neutrophils in thrombosis. The journey of TF through NETs","volume":"3","author":"Kambas","year":"2012","journal-title":"Front. Immunol."},{"key":"10.1016\/j.prostaglandins.2015.10.001_bib0355","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1161\/CIRCRESAHA.116.304944","article-title":"Coronary neutrophil extracellular trap burden and deoxyribonuclease activity in st-elevation acute coronary syndrome are predictors of ST-segment resolution and infarct size","volume":"116","author":"Mangold","year":"2015","journal-title":"Circ. Res."},{"key":"10.1016\/j.prostaglandins.2015.10.001_bib0360","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/S0741-5214(97)70210-6","article-title":"Prostaglandin E2 synthesis and cyclooxygenase expression in abdominal aortic aneurysms","volume":"25","author":"Holmes","year":"1997","journal-title":"J. Vasc. Surg."},{"key":"10.1016\/j.prostaglandins.2015.10.001_bib0365","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1172\/JCI107262","article-title":"Formation of prostaglandins during the aggregation of human blood platelets","volume":"52","author":"Smith","year":"1973","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.prostaglandins.2015.10.001_bib0370","doi-asserted-by":"crossref","first-page":"392","DOI":"10.3109\/09537104.2012.704648","article-title":"Effects on platelet function of an EP3 receptor antagonist used alone and in combination with a P2Y(12) antagonist both in-vitro and ex-vivo in human volunteers","volume":"24","author":"Fox","year":"2012","journal-title":"Platelets"}],"container-title":["Prostaglandins &amp; Other Lipid Mediators"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098882315300149?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098882315300149?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T03:17:53Z","timestamp":1748661473000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098882315300149"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":74,"alternative-id":["S1098882315300149"],"URL":"https:\/\/doi.org\/10.1016\/j.prostaglandins.2015.10.001","relation":{},"ISSN":["1098-8823"],"issn-type":[{"value":"1098-8823","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The receptor EP3 to PGE2: A rational target to prevent atherothrombosis without inducing bleeding","name":"articletitle","label":"Article Title"},{"value":"Prostaglandins & Other Lipid Mediators","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prostaglandins.2015.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}